2026 Autism and ABA Therapy M&A Market Update: A Deep Buyer Pool Is Creating Strategic Options for Autism & ABA Therapy
Is Now the Right Time to Sell Your Autism and ABA Therapy Business?
The Autism and Applied Behavior Analysis (ABA) therapy market has entered a new stage of its evolution. After more than a decade of private equity investment and rapid expansion, the sector is no longer defined by growth and access at all costs. Today, buyers are increasingly focused on clinical quality, payor alignment, and sustainable organic growth.
Importantly, this shift has not eliminated demand for high-quality ABA businesses, but it has created a wider divide between companies that are viewed as quality assets and those that carry greater operating risks. For independent business owners, the implication is significant: buyers remain active, but they are underwriting businesses differently than they did five years ago. The strongest valuations are increasingly reserved for businesses that can demonstrate proven clinical outcomes, strong local market share, scalable infrastructure, and consistent financial performance.
The Autism and ABA Therapy Market in 2026-2027: Why It Matters Now
The autism and ABA therapy market is entering a pivotal period. Underlying need and demand has never been stronger, with the CDC’s latest data estimating that approximately 1 in 31 children have been identified with autism, which is up meaningfully from prior reporting periods.1 Earlier diagnosis, broader insurance coverage, and increased awareness continue to expand the population seeking services, while many markets remain constrained by clinician and technician supply.
At the same time, reimbursement and utilization are coming under unprecedented scrutiny. States facing rapidly increasing Medicaid expenditures are beginning to respond with rate reductions, tighter prior authorization requirements, and greater oversight of treatment intensity.
The policy discussion is also shifting from simply expanding access to asking how much ABA is clinically appropriate and for how long. CMS has released a toolkit to help state Medicaid and CHIP agencies strengthen oversight of ABA services for children with autism.2, 3 Recent media coverage highlighted new federal guidance discouraging standardized prescriptions such as blanket 40-hour-per-week treatment plans and encouraging states to use individualized treatment plans, prior authorization, periodic reauthorization, and stronger supervision requirements.4 As an example, North Carolina has similarly emphasized that treatment intensity and duration should not exceed an individual beneficiary’s needs.
This dynamic creates a compelling backdrop for 2026–2027: rising demand is colliding with increasing reimbursement pressure and treatment-intensity discipline. For high-quality ABA organizations, this environment should increasingly reward clinical outcomes, appropriate utilization, strong BCBA and RBT retention, diversified payor relationships, and efficient delivery models that focus on titration of hours, rather than growth driven simply by maximizing authorized hours. The market opportunity remains significant, but the next phase of Autism and ABA therapy sector evolution will likely be defined by sustainable growth and demonstrated clinical value, not just volume of hours alone.
What Is My Autism and ABA Therapy Business Worth? Understanding Autism and ABA Therapy Valuations
For some of the reasons outlined above, valuations across the ABA market have become increasingly variable and asset specific. Industry market activity suggests that smaller and lower-middle-market ABA clinic operators may generally transact in the mid-single-digit to high-single-digit EBITDA multiple range, while scaled regional and platform-quality assets can command materially higher valuations into the double-digit EBITDA multiple range.
The distinction between the lower end and higher end of the market is increasingly driven by a company’s specific operating profile and characteristics.
Key Valuation Drivers
| Operating Characteristic | Lower-Multiple Profile | Higher-Multiple Profile |
| Regional Density | Dispersed geographic footprint | Leading market share within concentrated regions |
| Market Dynamics | Difficult reimbursement, regulation, or labor environment | Favorable reimbursement and clinician supply-demand dynamics |
| Clinical Quality | Limited differentiation around quality and outcomes | Market-leading clinical reputation and measurable outcomes |
| Management Team | Lean organization dependent on founder / key individuals | Experienced, institutional-quality management infrastructure |
| Growth Levers | Limited avenues beyond core ABA service offering | Multiple vectors including new centers, M&A, and adjacent services |
| Ability to Scale | Growth primarily dependent on acquisitions | Demonstrated organic growth and repeatable de novo model |
| Payor Contracts | Concentrated or below-market reimbursement | Favorable rates and longstanding payor relationships |
| Delivery Model | Operationally difficult or highly dispersed service delivery | Efficient clinic-based or hybrid delivery model |
Who Is Buying Autism and ABA Therapy Businesses Right Now?
The buyer universe has centered around two categories of buyers: PE-backed consolidators looking to build scale and private equity firms seeking platform investments.
- Large PE-Backed Consolidators: Institutional-backed platforms continue to pursue acquisitions that increase density in existing markets, add attractive new regions, or strengthen ancillary capabilities such as alternative settings (home, center, and school) and services (speech pathology, occupational therapy, etc.). The May 2026 acquisition of LittleLeaves Behavioral Services by LEARN Behavioral (backed by Gryphon Investors) illustrates the current thesis particularly well. Little Leaves operated ~18 centers across Maryland, Virginia, and Florida, giving LEARN increased density in existing markets while adding Florida to its footprint.
- New Platform Investors: New private equity sponsors are also entering the sector. In June 2026, Cathay Capital launched Ascendia Autism Care through its investment into Early Autism Services, which marked the 12th platform transaction in the last 24 months. Additionally, PE sponsors that had previously invested in and exited the space are now reinvesting in the sector, which serves as a strong indication of how sought after the sector has become.
Continued platform creation is particularly significant because new entrants frequently become aggressive buyers as they seek to build initial scale and work to develop a repeatable playbook for acquisitions.
Select Recent Autism and ABA Therapy Transactions: 2025-2026
| Date | Buyer | Target | Target Scale |
| June 2026 | Cathay Capital | Ascendia Autism Care | 20 centers in 8 states |
| May 2026 | LEARN Behavioral | Little Leaves Behavioral | 18 centers in MD, VA, FL |
| Jan 2026 | Aquitaine Capital | KidsChoice | 7 locations in OK |
| Jan 2026 | ACES ABA | Ally Pediatric Therapy | 9 clinics in AZ |
| Jan 2026 | Behavior Framework | Autism ETC | 5 locations in TN |
| Dec 2025 | Elysium Management | InBloom Autism Services | ~25 centers in 7 states |
| Aug 2025 | Achieve Partners | Westside Children’s Therapy | ~30 centers in Chicagoland area |
| May 2025 | NexPhase Capital | Behavior Frontiers | 26 centers across 12 states |
| Feb 2025 | Nautic Partners | Proud Moments ABA | 70 clinics in 12 states |
| Jan 2025 | Ascend Capital | Unison Therapy Services | Multidisciplinary provider |
Why 2026-2027 Is an Optimal Window for Autism and ABA Therapy Owners to Transact
- Valuation Multiples: Although valuations haven’t reached the peak of the pre-COVID wave, autism services businesses, for the right assets, still boast some of the highest multiples in healthcare services
- Current and Looming Payor Headwinds: Payors have made it increasingly difficult to operate without scale through rate cuts, as well as more stringent requirements around prior authorizations, oversight, and reauthorizations
- Successful Secondary Transactions: Over a dozen successful private equity-backed exits in the last 24 months have led to new sponsors taking interest in the sector
- Succession and Liquidity Optionality: Many owners who built their businesses during the 2014-2018 insurance mandate wave are now seeking avenues to monetize their business. A recapitalization event allows owners to “take chips off the table” in the near-term while retaining equity in a larger, more diversified entity.
PGP Perspective
Against a dynamic backdrop, PGP expects sustained deal activity for scaled, high-quality operators that is driven in part by a “consolidation of consolidators” as PE-backed platforms acquire or combine with other PE-backed platforms to realize synergies and accelerate scale. This dynamic should further increase appetite for add-on acquisitions, particularly in markets where there is meaningful geographic or operational overlap for buyers. Strategic acquirors have already become more selective and targeted in their M&A approach and are likely to continue requiring a clear strategic rationale and compelling value proposition to pursue a transaction.
In an environment characterized by increasing payor pressures, operators that demonstrate a strong commitment to quality, payor alignment, and measurable outcomes should be well positioned to differentiate themselves. As a result, we expect continued dispersion in valuations and transaction outcomes, with high-quality, scaled operators commanding greater interest and subscale or less differentiated businesses facing a more selective market.
For high-quality independent operators, this environment can create significant opportunities. For owners considering a transaction over the next 12–24 months, the question is increasingly not whether a market exists for their business, but rather which partnership structure best aligns with their objectives, and how their company can be best positioned to demonstrate the characteristics that the market is rewarding today.
Interested in learning more about market insights, valuation trends, and strategic opportunities?
Speak to a Senior BankerSources & Citations
Physician Growth Partners · This content is provided for informational purposes only and does not constitute legal, financial, or investment advice. All transaction data sourced as cited. © 2026 Physician Growth Advisors, LLC. All rights reserved.
Latest Market Updates


Considering a healthcare transaction? Start with a confidential conversation.
"*" indicates required fields



